Halozyme Therapeutics Inc (HALO)
47.65
+1.95
(+4.27%)
USD |
NASDAQ |
Nov 22, 10:29
Halozyme Therapeutics Total Return Level: 45.70 for Nov. 21, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 21, 2024 | 45.70 |
November 20, 2024 | 45.76 |
November 19, 2024 | 44.81 |
November 18, 2024 | 42.57 |
November 15, 2024 | 45.65 |
November 14, 2024 | 53.96 |
November 13, 2024 | 58.61 |
November 12, 2024 | 59.61 |
November 11, 2024 | 61.09 |
November 08, 2024 | 60.98 |
November 07, 2024 | 59.65 |
November 06, 2024 | 60.63 |
November 05, 2024 | 58.72 |
November 04, 2024 | 58.47 |
November 01, 2024 | 57.15 |
October 31, 2024 | 50.57 |
October 30, 2024 | 50.59 |
October 29, 2024 | 50.64 |
October 28, 2024 | 50.46 |
October 25, 2024 | 49.25 |
October 24, 2024 | 49.30 |
October 23, 2024 | 50.80 |
October 22, 2024 | 51.55 |
October 21, 2024 | 51.77 |
October 18, 2024 | 52.61 |
Date | Value |
---|---|
October 17, 2024 | 52.28 |
October 16, 2024 | 53.46 |
October 15, 2024 | 53.82 |
October 14, 2024 | 53.95 |
October 11, 2024 | 53.00 |
October 10, 2024 | 52.13 |
October 09, 2024 | 50.66 |
October 08, 2024 | 54.13 |
October 07, 2024 | 53.85 |
October 04, 2024 | 59.18 |
October 03, 2024 | 60.43 |
October 02, 2024 | 58.16 |
October 01, 2024 | 56.64 |
September 30, 2024 | 57.24 |
September 27, 2024 | 56.97 |
September 26, 2024 | 56.95 |
September 25, 2024 | 55.87 |
September 24, 2024 | 56.20 |
September 23, 2024 | 58.53 |
September 20, 2024 | 59.24 |
September 19, 2024 | 59.50 |
September 18, 2024 | 62.31 |
September 17, 2024 | 61.93 |
September 16, 2024 | 62.91 |
September 13, 2024 | 62.30 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
13.90
Minimum
Mar 18 2020
64.42
Maximum
Aug 28 2024
39.33
Average
40.24
Median
Total Return Level Benchmarks
Abbott Laboratories | 513.12 |
Novavax Inc | 8.04 |
Insulet Corp | 262.00 |
BioLife Solutions Inc | 25.39 |
TransMedics Group Inc | 79.34 |